z-logo
open-access-imgOpen Access
RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway
Author(s) -
Chenglin Han,
Shuxiao Chen,
Haizhen Ma,
Xiangchuan Wen,
Zilong Wang,
Yingkun Xu,
Xunbo Jin,
Xiao Yu,
Muwen Wang
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s300480
Subject(s) - gene knockdown , cancer research , in vivo , metastasis , oncogene , pi3k/akt/mtor pathway , medicine , biology , cancer , signal transduction , microbiology and biotechnology , gene , cell cycle , biochemistry
Ribophorin II (RPN2) is a highly conserved glycoprotein involved in the N-linked glycosylation of multiple proteins. RPN2 was reported to be associated with malignant phenotype in several tumors. However, the function of RPN2 in bladder cancer (BCa) remains unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here